These medications, including semaglutide and liraglutide, have demonstrated substantial efficacy in promoting weight loss and improving glycemic control, which can help mitigate related health issues such as cardiovascular disease, obesity, and type 2 diabetes
Before you start this medication, consider discussing the following with a healthcare provider: Use retatrutide only under a clinicians supervision, since data on its long-term safety is still incomplete
Because retatrutide does not yet have an approved label, it should not be described as covered for type 2 diabetes, obesity, chronic weight management, sleep apnea, or any other condition in routine care
Over time, life happened, and my weight crept back up to 215 lbs
Informaes de ensaio clnico indicam que, em 56 semanas, 62 % dos participantes perderam pelo menos 5% do peso, 34% perderam mais de 10% e 6% perderam 20%